SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
466 I'll chip in for that keg for Gordon, as well. Incidentally, beer works Russian Bear-12/10/1999
465 <I still think the issue of excluding patients from the Zev clinical trials Bob L-12/10/1999
464 I'm in on the keg too! That, hem, goes without saying!Bob L-12/10/1999
463 Bob, joining the chorus is not enough. You gotta pitch in for the KEG, BLA or Pseudo Biologist-12/10/1999
462 Gordon, I join the chorus. Thanks, thanks. Bob L-12/10/1999
461 Thanks so much for the DD... I'll certainly be chipping in on that KEG. :) LLCF-12/10/1999
460 Guffaw Well, we know who's in a party mood this Holiday Season. <g>scaram(o)uche-12/10/1999
459 >>Thanks for the EXTENSIVE due diligence; we owe you a beer. Heck, as sooRCMac-12/10/1999
458 Gordon, Thanks for the EXTENSIVE due diligence; we owe you a beer. Heck, as sbiowa-12/10/1999
457 Gordon, thanks for the informative posts. V1Vector1-12/10/1999
456 Gordon, thanks for the detailed reports. It does sound like Dr. Leonard was quPseudo Biologist-12/10/1999
455 Peter, <i>Looking at the disclosed side effects of CHOP and the Rit+CHOPGordon James-12/10/1999
454 biowa, While perusing the lymphoma posters Saturday morning at the conference,Gordon James-12/9/1999
453 <i><<We once concluded that NERX was using C2B8 for initial studiestnsaf-12/9/1999
452 Thanks. Didn't mean to sound negative about NERX. Actually, quite admire scaram(o)uche-12/9/1999
451 For NHL, yes they were using Rituxan. But I think they are looking at other caPseudo Biologist-12/9/1999
450 Jason: We once concluded that NERX was using C2B8 for initial studies. Canscaram(o)uche-12/8/1999
449 I don't recall any mention of the October 1999 "Current Opinion in Immtnsaf-12/8/1999
448 Al, It would be very risky imo to use Zev in combo with CHOP without using doseVector1-12/7/1999
447 V1, <<Zev will not compete in front line treatment as DNA/IDPH will not biowa-12/7/1999
446 Biowa, I think the battle in first line treatment will be CHOP plus Rit v. FludVector1-12/7/1999
445 V1, That's a fairly negative evaluation of Zevalin. I have to agree that biowa-12/7/1999
444 By Stephanie O'Brien, CBS MarketWatch Last Update: 5:41 PM ET Dec 6, 1999 MVector1-12/6/1999
443 This could explain the big drop in IDPH today. In patients who failed Rit the ZVector1-12/6/1999
442 DAK, Thanks, I know that the 81% overall compares roughly equivalent to Zevalibiowa-12/6/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News